Literature DB >> 26209471

Agreement Between Responses From Community-Dwelling Persons With Stroke and Their Proxies on the NIH Neurological Quality of Life (Neuro-QoL) Short Forms.

Allan J Kozlowski1, Ritika Singh2, David Victorson2, Ana Miskovic3, Jin-Shei Lai2, Richard L Harvey4, David Cella2, Allen W Heinemann5.   

Abstract

OBJECTIVE: To examine agreement between patient and proxy responses on the Quality of Life in Neurological Disorders (Neuro-QoL) instruments after stroke.
DESIGN: Cross-sectional observational substudy of the longitudinal, multisite, multicondition Neuro-QoL validation study.
SETTING: In-person, interview-guided, patient-reported outcomes. PARTICIPANTS: Convenience sample of dyads (N=86) of community-dwelling persons with stroke and their proxy respondents.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Dyads concurrently completed short forms of 8 or 9 items for the 13 Neuro-QoL adult domains using the patient-proxy perspective. Agreement was examined at the scale-level with difference scores, intraclass correlation coefficients (ICCs), effect size statistics, and Bland-Altman plots, and at the item-level with kappa coefficients.
RESULTS: We found no mean differences between patients and proxies on the Applied Cognition-General Concerns, Depression, Satisfaction With Social Roles and Activities, Stigma, and Upper Extremity Function (Fine Motor, activities of daily living) short forms. Patients rated themselves more favorably on the Applied Cognition-Executive Function, Ability to Participate in Social Roles and Activities, Lower Extremity Function (Mobility), Positive Affect and Well-Being, Anxiety, Emotional and Behavioral Dyscontrol, and Fatigue short forms. The largest mean patient-proxy difference observed was 3 T-score points on the Lower Extremity Function (Mobility). ICCs ranged from .34 to .59. However, limits of agreement showed dyad differences exceeding ±20 T-score points, and item-level agreement ranged from not significant to weighted kappa=.34.
CONCLUSIONS: Proxy responses on Neuro-QoL short forms can complement responses of moderate- to high-functioning community-dwelling persons with stroke and augment group-level analyses, but do not substitute for individual patient ratings. Validation is needed for other stroke populations.
Copyright © 2015 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Proxy; Quality of life; Rehabilitation; Stroke

Mesh:

Year:  2015        PMID: 26209471      PMCID: PMC4628567          DOI: 10.1016/j.apmr.2015.07.005

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  19 in total

1.  Transitions in spousal caregiving.

Authors:  Lynda C Burton; Bozena Zdaniuk; Richard Schulz; Sharon Jackson; Calvin Hirsch
Journal:  Gerontologist       Date:  2003-04

2.  Assessing quality of life after stroke. The value and limitations of proxy ratings.

Authors:  K C Sneeuw; N K Aaronson; R J de Haan; M Limburg
Journal:  Stroke       Date:  1997-08       Impact factor: 7.914

3.  Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate, and unbiased?

Authors:  P J Dorman; F Waddell; J Slattery; M Dennis; P Sandercock
Journal:  Stroke       Date:  1997-10       Impact factor: 7.914

4.  Use of the Health Utilities Index with stroke patients and their caregivers.

Authors:  S D Mathias; M M Bates; D J Pasta; M G Cisternas; D Feeny; D L Patrick
Journal:  Stroke       Date:  1997-10       Impact factor: 7.914

5.  Evaluation of proxy responses to the Stroke Impact Scale.

Authors:  Pamela W Duncan; Sue Min Lai; Denise Tyler; Subashan Perera; Dean M Reker; Stephanie Studenski
Journal:  Stroke       Date:  2002-11       Impact factor: 7.914

6.  Development of a stroke-specific quality of life scale.

Authors:  L S Williams; M Weinberger; L E Harris; D O Clark; J Biller
Journal:  Stroke       Date:  1999-07       Impact factor: 7.914

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  Symptom experiences: perceptual accuracy between advanced-stage cancer patients and family caregivers in the home care setting.

Authors:  Michelle M Lobchuk; Lesley F Degner
Journal:  J Clin Oncol       Date:  2002-08-15       Impact factor: 44.544

9.  Family caregiver perspective-taking and accuracy in estimating cancer patient symptom experiences.

Authors:  Michelle M Lobchuk; Jacquie D Vorauer
Journal:  Soc Sci Med       Date:  2003-12       Impact factor: 4.634

10.  Measuring agreement between patient and proxy responses to multidimensional health-related quality-of-life measures in clinical trials. An application of psychometric profile analysis.

Authors:  Kevin P Weinfurt; Sara M Trucco; Richard J Willke; Kevin A Schulman
Journal:  J Clin Epidemiol       Date:  2002-06       Impact factor: 6.437

View more
  14 in total

1.  Comparison of 3-Month Stroke Disability and Quality of Life across Modified Rankin Scale Categories.

Authors:  Srikant Rangaraju; Diogo Haussen; Raul G Nogueira; Fadi Nahab; Michael Frankel
Journal:  Interv Neurol       Date:  2016-11-16

2.  Linking of the quality of life in neurological disorders (Neuro-QoL) to the international classification of functioning, disability and health.

Authors:  Alex W K Wong; Stephen C L Lau; David Cella; Jin-Shei Lai; Guanli Xie; Lidian Chen; Chetwyn C H Chan; Allen W Heinemann
Journal:  Qual Life Res       Date:  2017-05-05       Impact factor: 4.147

3.  What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey.

Authors:  Olivier D R van Wulfften Palthe; Stein J Janssen; Jay S Wunder; Peter C Ferguson; Guo Wei; Peter S Rose; Micheal J Yaszemski; Franklin H Sim; Patrick J Boland; John H Healey; Francis J Hornicek; Joseph H Schwab
Journal:  Spine J       Date:  2016-11-14       Impact factor: 4.166

4.  Trade-Offs in Quality-of-Life Assessment Between the Modified Rankin Scale and Neuro-QoL Measures.

Authors:  Robert L Askew; Carmen E Capo-Lugo; Rajbeer Sangha; Andrew Naidech; Shyam Prabhakaran
Journal:  Value Health       Date:  2020-09-01       Impact factor: 5.725

5.  Differential Effects of Time to Initiation of Therapy on Disability and Quality of Life in Patients With Mild and Moderate to Severe Ischemic Stroke.

Authors:  Robert L Askew; Carmen E Capo-Lugo; Andrew Naidech; Shyam Prabhakaran
Journal:  Arch Phys Med Rehabil       Date:  2020-05-22       Impact factor: 3.966

6.  Association of self-reported cognitive concerns with mobility in people with lower limb loss.

Authors:  Valerie E Kelly; Sara J Morgan; Dagmar Amtmann; Rana Salem; Brian J Hafner
Journal:  Disabil Rehabil       Date:  2016-10-19       Impact factor: 3.033

7.  Quality of Life in Physical, Social, and Cognitive Domains Improves With Endovascular Therapy in the DEFUSE 3 Trial.

Authors:  Laura C Polding; William J Tate; Michael Mlynash; Michael P Marks; Jeremy J Heit; Soren Christensen; Stephanie Kemp; Gregory W Albers; Maarten G Lansberg
Journal:  Stroke       Date:  2021-02-18       Impact factor: 7.914

8.  Patient-rated versus proxy-rated cognitive and functional measures in older adults.

Authors:  Molly Howland; Kevin C Allan; Caitlin E Carlton; Curtis Tatsuoka; Kathleen A Smyth; Martha Sajatovic
Journal:  Patient Relat Outcome Meas       Date:  2017-03-15

9.  Patient-proxy agreement on change in acute stroke patient-reported outcome measures: a prospective study.

Authors:  Brittany R Lapin; Nicolas R Thompson; Andrew Schuster; Irene L Katzan
Journal:  J Patient Rep Outcomes       Date:  2021-07-06

10.  An Initial Empirical Operationalization of the Earliest Stages of the Alzheimer's Continuum.

Authors:  Andrew M Kiselica; Alyssa N Kaser; Jared F Benge
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Jan-Mar 01       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.